Mizuho Maintains Outperform on IDEAYA Biosciences, Lowers Price Target to $39
Benzinga Newsdesk 4 hours ago
Analyst RatingsNewsPrice Target
Mizuho analyst Graig Suvannavejh maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and lowers the price target from $44 to $39.
Mizuho analyst Graig Suvannavejh maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and lowers the price target from $44 to $39.